Ultragenyx Pharmaceutical
RARE
#4449
Rank
โ‚น213.89 B
Marketcap
โ‚น2,217
Share price
0.71%
Change (1 day)
-41.01%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2025 (TTM): -โ‚น514.52

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น543.29. In 2024 the company made an earnings per share (EPS) of -โ‚น579.88 an increase over its 2023 EPS that were of -โ‚น761.89.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น514.52-11.27%
2024-โ‚น579.88-23.89%
2023-โ‚น761.89-17.61%
2022-โ‚น924.6950.67%
2021-โ‚น613.72113.69%
2020-โ‚น287.19-55.9%
2019-โ‚น651.2282.56%
2018-โ‚น356.71-45.15%
2017-โ‚น650.3014.68%
2016-โ‚น567.07
2014-โ‚น212.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Lexicon Pharmaceuticals
LXRX
-โ‚น17.38-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น45.73-91.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.06-98.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น248.78-145.79%๐Ÿ‡บ๐Ÿ‡ธ USA